Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 4, 2011, Pages 327-335

  Kleist, Britta ^a   Xu, Li ^a   Li, Guojun ^a   Kersten, Christian ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Soerlandet sykehus HF ^*  (Norway)

Author keywords

Lgr5; Metastasis; Stem cell like cells; Tumor compartments

Indexed keywords

G PROTEIN COUPLED RECEPTOR; LGR5 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER STEM CELL; CARCINOMA; CHEMISTRY; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; TUMOR MARKERS, BIOLOGICAL;

EID: 80051603461     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Vries RG, Huch M and Clevers H. Stem cells and cancer of the stomach and intestine. Mol Oncol 2010; 4:373-384
2. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res 2006; 66:9339-9344.
3. Brabletz S, Schmalhofer O, and Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol 2009; 217:307-317. DOI: 10.1002/path.2475.
4. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-1007. DOI: 10.1038/ nature06196
5. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, van den Born M, Danenberg E, Clarke AR, Sansom OJ and Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009;457:608-612. DOI: 10.1038/nature07602.
6. Vermeulen L, Todaro M, De Sousa Mello F, Sprick MR, Kemper K, Alea MP, Richel DJ, Stassi G and Medema JP. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. PNAS 2008;105:13427-13432.
7. Becker L, Huang Q and Mashimo H. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. The Scientific World-JOURNAL 2008; 8:1168-1176. DOI 10.1100/tsw.2008.148
8. Takahashi H, Ishii H, Nishida N, Takemasa I, Mizushima T, Ikeda M, Yokobori T, Mimori K, Yamamoto H, Sekimoto M, Doki Y and Mori M. Significance of Lgr5+ve cancer stem cells in the colon and rectum. Ann Surg Oncol 2011; 18:1166-1174. DOI 10.1245/s10434-010-1373-9.
9. Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T and Dosaka-Akita H. Expression of Lgr5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Anticancer Res 2011;31:263-270.
10. Becker L, Huang Q and Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus 2010;23;168-174.
11. Prall F, Nizze H and Barten M. Tumor budding as prognostic factor in stage I/II colorectal carcinoma. Histopathology 2005; 47:17-24. DOI: 10.1111/j.1365-2559.2005.02161.x
12. Zlobec I, Baker K, Minoo P, Jass JR, Terracciano L and Lugli A. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clin Cancer Res 2008; 14:143-148. DOI:10.1158/1078-0432.CCR-07-1380.
13. Liebig C, Ayala G, Wilks J, Verstovsek G, Liu H, Agarwal N, Berher DH and Albo D. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol 2009; 27: 5131-5137. DOI: 10.1200/JCO.2009.22.4949.
14. Hamilton SR, Aaltonen LA (Eds.) (2000) World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. IARC Press: Lyon, pp 110-111
15. TNM classification of malign tumors (2009) edited by L.H. Sobin, M.K. Gospodarowicz and Ch. Wittekind.- 7th ed., pp 100-105
16. Maeda S, Shinchi H, Kurahara H, Mataki Y, Maemura K, Sato M, Natsugoe S, Aikou T and Takao S. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer. Br J Cancer 2008; 98:1389-1397.
17. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T and Jung A. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009; 219:427-434.DOI: 10.1002/path.2597
18. Fodde R and Brabletz T. Wnt/β-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007; 19:1-9.
19. Kirchner T and Brabletz T. Patterning and β-catenin expression in the colonic adenomacarcinoma sequence: analogies with embryonic gastrulation. Am J Pathol 2000; 157:1113-1121.
20. Fan X-S, Wu H-Y, Yu H-P, Zhou Q, Zhang Y-F and Huang Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with β-catenin. Int J Colorectal Dis 2010;25:583-590. DOI 10.1007/s00384-010-0903-z
21. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B and Behrens A. JNK signaling modulates intestinal homeostasis and tumorigenesis in mice. EMBO J 2009; 28:1843-1854.
22. Gespach C. Stem cells and colon cancer: The questionable cancer stem cell hypothesis. Gastroenterol Clin Biol 2010; 34:653-661.
23. Mueller MT, Hermann PC and Heeschen C. Cancer stem cells as new therapeutic target to prevent tumor progression and metastasis. Front Biosci (Elite Ed) 2010; 2:602-613.
24. Tsuchiya A, Ando Y, Kikuchi Y, Kanazawa M, Sato H and Abe R. Venous invasion as a prognostic factor in colorectal cancer. Surg Today 1995; 25:950-953
25. Shipitsin M and Polyak K. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 2008; 88:459-463.
26. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C and Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104:10158-10163.
27. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D and Rafii S. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118:2111-2120